TSHA- Taysha Gene Therapies, Inc.

TSHA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Nolan Sean P.	2.91M	$13.41M	-
CFO	Alam Kamran	1.44M	$6.52M	-
Dir	Stalfort John A III	1.18M	-	-
Pres	Nagendran Sukumar	936.4K	$5.84M	-
Dir	Donenberg Phillip B.	241.3K	-	-

Buys and sells only

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 23, 2023	Session R.A. II	10% Owner	Sell	28,608	$0.70	$20,119.13	-0.3%	+359.1%	+348.5%
Jun 21, 2023	Session R.A. II	10% Owner	Sell	434,615	$0.71	$307,843.98	-4.6%	+365.6%	+294.2%
May 16, 2023	Nagendran Sukumar49	President And Head Of R&D	Buy	5,000	$0.68	$3,400.00	+17.1%	+207.8%	+349.4%
Oct 31, 2022	Manning Paul B54	Director, 10% Owner	Buy	1,500,000	$2.00	$3,000,000.00	+1,055%	-10.5%	+36.0%
Aug 23, 2022	Alam Kamran83	Chief Financial Officer	Sell	3,325	$3.47	$11,537.75	-1.2%	-36.0%	-36.0%
Aug 22, 2022	Alam Kamran83	Chief Financial Officer	Sell	28,675	$3.70	$105,999.12	-9.6%	-35.3%	-42.0%
Jul 6, 2022	Prasad Suyash90	CMO And Head Of R&D	Sell	12,861	$3.70	$47,649.79	-2.4%	-45.5%	-82.5%
Jul 1, 2022	Prasad Suyash90	CMO And Head Of R&D	Sell	50,139	$3.65	$183,080.87	-8.4%	-41.4%	-80.8%
Feb 3, 2022	Manning Paul B54	Director, 10% Owner	Buy	201,602	$7.80	$1,571,809.68	+10.7%	-45.1%	-84.4%
Feb 2, 2022	Nagendran Sukumar49	Director	Buy	10,000	$8.01	$80,100.00	+52.0%	-44.0%	-84.6%